Sandra Levy
ARTICLES BY THIS AUTHOR
- 1/24/2021
Alembic gets FDA nod for generic ProAmatine
Midodrine hydrochloride tablets have a market value of roughly $60 million for the 12 months ended September 2020, according to IQVIA. - 1/21/2021
Amazon, Walmart stand ready to assist with national COVID-19 vaccine rollout
Amazon has reached out to President Biden to help with the national deployment of COVID-19 vaccines, and Walmart has made a public announcement that it is prepared to assist as well. - 1/21/2021
Camber intros generic Effexor
Camber's generic Effexor is available in dosage strengths of 37.5 mg, 75 mg, 150 mg and 225 mg. - 1/21/2021
Industry orgs praise Biden’s COVID-19 national strategy
In separate statements, various industry organizations lauded President Biden’s “National Strategy for the COVID-19 Response and Pandemic Preparedness.” - 1/20/2021
Janet Woodcock to lead FDA as acting commissioner
Janet Woodcock, director of the Food and Drug Administration’s Center for Drug Evaluation and Research, will serve as acting commissioner of the agency. - 1/20/2021
CVS Health, Walgreens pharmacies to roll out COVID-19 vaccines in Massachusetts
Starting this week, at least 15 CVS Health and Walgreens, located in areas of Massachusetts where there is currently less access to convenient vaccine sites, will receive a total of 10,000 COVID-19 vaccines to administer. - 1/19/2021
NACDS’ Anderson highlights members’ health positioning in U.S. Chamber of Commerce report
The National Association of Chain Drug Stores’ memberships’ vital role in serving Americans throughout the pandemic and beyond has been included in The U.S. Chamber of Commerce’s high-profile “State of American Business” report. - 1/19/2021
Merck obtains FDA nod for Verquvo
Merck's Verquvo offers a new treatment option for appropriate patients with symptomatic chronic heart failure. - 1/18/2021
NCPA files lawsuit against HHS to eliminate pharmacy DIR fees
The National Community Pharmacists Association filed a lawsuit against the Department of Health and Human Services regulations, alleging that DIR fees are without reasonable transparency and that they conceal the true cost of prescription drugs. - 1/18/2021
Pfizer suing Aurobindo over generic Xeljanz
Pfizer is seeking a court order blocking Aurobindo from making generic copies of Zeljanz until the patents expire in March 2023 and December 2025.
